News
July 16, 2012 — Reva Medical Inc. announced it completed clinical enrollment with the ReZolve drug-eluting bioresorbable scaffold. A total of 26 patients have been enrolled and there are no major adverse coronary events (MACE) reported to date.
July 16, 2012
News
July 16, 2012 — LipoScience Inc., an in vitro diagnostic company developing clinical diagnostic tests using nuclear magnetic resonance (NMR) technology, announced publication of the findings of a clinical study in the current issue of the Journal of the American College of Cardiology indicating that high density lipoprotein (HDL) particle number has a stronger, more independent association with coronary heart disease and carotid atherosclerosis than HDL cholesterol (HDL-C).
July 16, 2012Feature | Kevin E. Steel, D.O., FACC, Cardiologist
July 16, 2012 — Medical imaging has always been an important part of clinical trials. Echocardiography, which uses sound waves to create moving real-time images of cardiac structure and function, provides an excellent noninvasive method to evaluate the impact of therapeutics on cardiac morphology.
July 16, 2012Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
July 16, 2012 — The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $4.78 million grant to researchers at Cleveland Clinic’s Lerner Research Institute to use metabolomics — a new approach that focuses on the small-molecule byproducts of metabolism — for discovery of novel pathways linked to the development of cardiovascular diseases.
July 16, 2012News
July 16, 2012 — Cardiosolutions Inc., an early-stage company focused on the development of an innovative percutaneous system to treat patients with moderate to severe mitral valve regurgitation, today announced it has received a minority investment from Sorin Group. Sorin is a global medical device company and develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.
July 16, 2012
News
July 16, 2012 — The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of Alere Triage products. Identified lots may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results.
July 16, 2012Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
Feature | Partho P Sengupta, M.D., DM, FASE
Echocardiography is a natural application for telemedicine, as handheld ultrasound devices and cloud-based transmission solutions make it possible to perform a test at a remote location and have consultation, in real time, by an expert thousands of miles away. Telemedicine can eliminate the need for travel, reduce wait time for test results, and is cost effective.
July 13, 2012
News
July 13, 2012 — GE Healthcare and VPDiagnostics Inc. jointly announced today their co-marketing agreement for the VPDiagnostics’ MRI-PlaqueView software for carotid artery atherosclerosis analysis.
July 13, 2012Technology
July 13, 2012 — Angioslide Ltd., a provider of embolic capture angioplasty solutions, today announced the successful deployment of a 3x100 mm Proteus device for treating peripheral artery disease (PAD) in below-the-knee (BTK) vasculature at Community Hospital in Munster, Ind.
July 13, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Radial Access
In the United States, radial artery catheterization is performed in the minority of diagnostic angiograms and cardiac stenting procedures despite the benefits it offers to patients in terms of reduced complications and faster mobility after the procedure. However, new data now suggests there might also be a cost savings. Research from the Perelman School of Medicine at the University of Pennsylvania, the University of Washington Medical Center, and the University of Pittsburgh School of Medicine, indicates that radial access may also offer a significant cost savings benefit to hospitals. The findings are published online first in Circulation: Cardiovascular Quality and Outcomes.
July 13, 2012News
July 13, 2012 — Royal Philips Electronics announced that it has embarked on a five-year joint research and development (R&D) program with the St. Petersburg State Polytechnical University, the Vavilov State Optical Institute and the Ioffe Physical Technical Institute.
July 13, 2012
Feature
An otherwise healthy pregnant woman who suffered cardiac arrest and was resuscitated, therapeutically cooled and then re-warmed, delivered a healthy, full-term baby 19 weeks later. Researchers published a unique case report online last week in Annals of Emergency Medicine.
July 13, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
July 12, 2012 — BioControl Medical has announced U.S. Food and Drug Administration (FDA) approval to begin the second phase of INOVATE-HF (Increase Of Vagal Tone in Heart Failure), a global, multi-center, investigational device exemption (IDE) clinical study of the company’s CardioFit system for heart failure.
July 12, 2012
Feature | Marianne Pop, Pharm.D., BCPS
Over the past decade there have been several advancements in prothrombin time (PT)/international normalized ration (INR) point-of-care testing (POCT) devices. This is usually performed at an outpatient Coumadin clinic or at the physician’s office, which can be inconvenient for patients, so there is a growing trend toward patient self-testing (PST) devices.
July 12, 2012News
July 12, 2012 — Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation, a U.S. subsidiary of Terumo Corporation, announced the completion of U.S. patient enrollment in the Occlusive/StenoticPeripheral Artery Revascularization Study (OSPREY) designed to evaluate the safety and effectiveness of the Misago self-expanding stent system.
July 12, 2012